1. Home
  2. BNZI vs AIDX Comparison

BNZI vs AIDX Comparison

Compare BNZI & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.85

Market Cap

5.7M

Sector

N/A

ML Signal

HOLD

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.43

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNZI
AIDX
Founded
2016
N/A
Country
United States
United States
Employees
34
14
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
6.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNZI
AIDX
Price
$1.85
$0.43
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$24.00
N/A
AVG Volume (30 Days)
198.5K
124.8K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.28
N/A
Revenue Next Year
$0.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.40
52 Week High
$8.10
$14.09

Technical Indicators

Market Signals
Indicator
BNZI
AIDX
Relative Strength Index (RSI) 37.36 29.57
Support Level $1.00 N/A
Resistance Level $1.96 $0.57
Average True Range (ATR) 0.21 0.04
MACD -0.05 0.00
Stochastic Oscillator 16.06 15.90

Price Performance

Historical Comparison
BNZI
AIDX

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: